Sinucon Tablets is a medicine brand authorised in South Africa. This page provides limited product identification information only .
Medicine name : Sinucon Tablets
Country: South Africa
Schedule: S2
Active ingredients : Per Tablet
| Product / Strength | Active Ingredient | Strength | Inactive Ingredient / Sugar Content | Strength |
|---|---|---|---|---|
| SINUCON tablet | Paracetamol | 200 mg | Lactose | 148.00 mg |
| SINUCON tablet | Ephedrine hydrochloride | 6 mg | — | — |
| SINUCON tablet | Caffeine | 20 mg | — | — |
| SINUCON tablet | Chlorpheniramine maleate | 2 mg | — | — |
Sinucon Tablets is a scheduled medicine in South Africa. Detailed information, including its uses, warnings, precautions, dosage guidance and possible side effects, is intended only for registered healthcare professionals or for patients to whom the medicine has been legally prescribed.
This page does not provide medical advice, treatment recommendations, promotional claims, or instructions for use. Please consult a registered doctor, pharmacist, or other qualified healthcare professional for information specific to your condition and prescription.
For your safety, do not use Sinucon Tablets unless it has been prescribed or supplied to you in accordance with South African medicine regulations.
Manufacturer/holder
Shanur Healthcare (Pty) Ltd
Loch House Unit 003
3A Eton Road, Parktown
Johannesburg, 2193
SAHPRA / product identifier : G979 (Act 101/1965)
Sources
Written by: RxZest Editorial Team
Editorial review: Checked for readability, structure, and source alignment
Based on SAHPRA-approved information : Sinucon Tablets
Last updated: [13/05/2026]
